Convergen: Funding, Investors & Team (Sep 2026)
Convergen develops targeted protein degradation therapies for diseases associated with pathological protein aggregates.
Convergen has raised $15.0M across 1 funding round on record, the most recent a Seed of $15.0M announced in Aug 2026.
That round is in line with the $15M median round size for China companies tracked on FundedIQ over the last two years.
Convergen Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Convergen Funding Rounds
Convergen Investors
Convergen Founders and Leadership Team
Contact details for the Convergen team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Convergen Funding in Context
Convergen's latest round of $15.0M is in line with the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Convergen in Biopharma and Suzhou
Companies Similar to Convergen
Ubot Robotics is dedicated to developing leg-and-foot bionic robots.
Mogulinker Technology is a domestic SaaS software provider specializing in the post industrial equipment…
Medefa is a startup that uses cutting-edge synthetic biology engineering technologies to mass-produce novel…
VAST develops generative AI technologies for 3D content creation and virtual world-building.
Violoop develops AI hardware and software that enables computers to perform tasks across applications using…
Kossel Medical is a medical device R&D, manufacturer of vascular interventional devices to provide clinical…
Haofeng Medtech is a CDMO service provider of interventional medical devices.
Nova Fusion is a nuclear fusion energy company that develops small modular reactors for distributed power…
Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule…
Miwei Technology is a space-based intelligent computing service provider.
Lingchu is an embodied intelligence startup company that specializes in robot skill set training using…
MileBot Robotics is a robot start-up company in the field of medical and health.
Convergen Funding FAQs
What does Convergen do?
Convergen develops targeted protein degradation therapies for diseases associated with pathological protein aggregates.
How much funding has Convergen raised?
Convergen has raised $15.0M across 1 round on record. The most recent is a Seed of $15.0M announced in Aug 2026.
When did Convergen last raise funding?
Convergen's most recent funding round on record is a Seed of $15.0M, announced in Aug 2026.
Who has invested in Convergen?
Investors on record for Convergen include Qiming Venture Partners, Matrix Partners China, Lilly Asia Ventures, Hillhouse Capital, BioTrack Capital.
Who founded Convergen?
FundedIQ lists Jinquan Sun (Founder and CEO) at Convergen.
Where is Convergen headquartered?
Convergen is based in Suzhou, China.
How many employees does Convergen have?
Convergen is in the 11-50 employee band.
When was Convergen founded?
Convergen was founded in 2020.
About FundedIQ's Convergen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Convergen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.